MANGOCEUTICALS, INC. Balance Sheet
MGRX|3 years of annual SEC 10-K data (FY2023-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$16M
FY2025
Cash
$1M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$15M
FY2025
MANGOCEUTICALS, INC. had $16M in total assets and $15M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Piotroski F-Score: 2/9 criteria passed
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash & Equivalents | $1.5M | $58.7K | $739.0K |
| Inventory | - | - | $18.5K |
| Current Assets | $1.5M | $75.6K | $818.5K |
| PP&E (Net) | $1.8K | $2.8K | $96.1K |
| Total Assets | $16.1M | $15.4M | $1.1M |
| Current Liabilities | $890.6K | $1.4M | $211.1K |
| Shareholders' Equity | $15.2M | $13.9M | $774.8K |